Related Experiment Video
Updated: Jul 6, 2026
11:14
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
Vanadium compounds biological actions and potential as pharmacological agents
1Department of Medicine, Mount Sinai Hospital,Toronto, Ontario, M5G 1X5,Canada; Department of Physiology and Banting and Best Diabetes Centre, University of Toronto,Toronto, Ontario, M5G 1X5,Canada.
Trends in Endocrinology and Metabolism: TEM
|March 1, 1997
Summary
Vanadium compounds show promise for treating type II diabetes by enhancing insulin sensitivity. However, long-term safety concerns due to potential side effects require further investigation.
Area of Science:
- Biochemistry
- Endocrinology
- Pharmacology
Background:
- Vanadium compounds have been anecdotally proposed as therapeutic agents.
- Vanadate inhibits protein tyrosine phosphatases and mimics insulin's biological actions.
- This suggests a potential role for vanadium in diabetes mellitus therapy.
Purpose of the Study:
- To explore the therapeutic potential of vanadium compounds in diabetes mellitus.
- To investigate the mechanism of action and efficacy of vanadium in improving insulin sensitivity.
- To assess the suitability of vanadium compounds for type II diabetes mellitus treatment.
Main Methods:
- Review of existing studies on vanadium compounds in diabetes research.
- Analysis of enzyme inhibition by vanadate, particularly protein tyrosine phosphatases.
- Evaluation of insulin-mimetic effects and metabolic stimulation by vanadium compounds.
Main Results:
- Vanadium compounds enhance insulin sensitivity in rodent and human diabetic subjects.
- These agents stimulate metabolic effects independently of the insulin receptor.
- Therapeutic targeting is suggested to be preferential toward type II diabetes mellitus.
Conclusions:
- Vanadium compounds show potential for treating type II diabetes by improving insulin sensitivity.
- Long-term safety is a concern due to tissue accumulation and enzyme inhibition non-specificity.
- Further research on mechanism, chronic effects, and specificity is warranted.
Related Concept Videos
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:21Pharmacodynamics: Overview and Principles
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...